GIST SupportGIST Support Wiki

 
Bevacizumab (Avastin) and Gleevec

dellida This page is for information related to Bevacizumab (Avastin) and Gleevec, one of the combination trials under Clinical Trial Drugs. Feel free to add your own experiences with the trial in the comments section or any other links to useful resources.

[edit] Basic Information

Manufacturer: Bevacizumab (Avastin) is manufactured by Genentech. Imatinib (Gleevec) is manufactured by Novartis.

Molecular Targets: Bevacizumab targets VEGF, the angiogenesis growth factor

Trial: Phase I trial of this drug combination is listed but not yet recruiting - follow this link

GIST Support International website page: link here

[edit] Comments from Trial Participants

Retrieved from "http://gistsupport.medshelf.org/Bevacizumab_%28Avastin%29_and_Gleevec"